Atlas Trials

Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning

Clinical trial NCT00937261 · UNKNOWN

Trial details

NCT number
NCT00937261
Sponsor
University of California, Irvine
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2009-07-01
Primary completion
2010-07-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.